Terazosin vs finasteride for BPH.
Zacks
M
M
Ohio State University, Columbus, USA. zacksm@ohsu.edu
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D016896:Treatment Outcome; D014554:Urination / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D010919:Placebos; D018120:Finasteride; C041226:Terazosin; D011224:Prazosin